2 Best SPACs to Buy Based on Jonathan Esfandi’s JNE Partners’ Latest Portfolio

Page 1 of 2

In this article, we discuss the 2 best SPACs to buy Based on Jonathan Esfandi’s JNE Partners’ latest portfolio. If you want to see our detailed analysis of the best SPACs according to JNE, go directly to the 7 Best SPACs to Buy Based on Jonathan Esfandi’s JNE Partners’ Latest Portfolio.

2. Orion Biotech Opportunities Corp. (NASDAQ:ORIA)

Esfandi’s Stake Value: $15,075,000

Percentage of Jonathan Esfandi’s 13F Portfolio: 11.06%

Orion Biotech Opportunities Corp. (NASDAQ: ORIA) is a blank check company that intends to affect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. Orion Biotech Opportunities Corp. (NASDAQ: ORIA) was founded in 2021 and is based in New York, New York.

This May, Orion Biotech Opportunities Corp. (NASDAQ: ORIA) announced the closing of its initial public offering of 20 million units at a price of $10.00 per unit, resulting in total gross proceeds of $200 million. The company’s units began trading on The Nasdaq Capital Market under the symbol “ORIAU” on May 13, 2021.

According to the latest filings, JNE Partners owned 1.5 million shares in the company by the end of June 2021 worth over $15 million, representing 11.06% of the portfolio.

Page 1 of 2